Tilray Brands (TLRY) Intangibles (2017 - 2026)
Tilray Brands' (TLRY) quarterly Intangibles came in at $58.0 million in Q2 2026, down 96.44% YoY from $1.6 billion in Q2 2025, and up 54.15% on a QoQ basis from $37.6 million in Q1 2026.
Tilray Brands (TLRY) Intangibles (2017 - 2026) Analysis & Trends
Tilray Brands (TLRY) has 10 years of Intangibles data on file, last reported at $58.0 million in Q2 2026.
- Quarterly Intangibles fell 96.44% year-over-year to $58.0 million in Q2 2026, while the trailing twelve-month figure through May 2026 was $58.0 million (down 96.44% YoY) and the FY2026 annual result came in at $58.0 million, down 96.44% from the prior year.
- Intangibles improved to $58.0 million in Q2 2026, from $37.6 million in the prior quarter.
- In the past five years, Intangibles ranged from a high of $1.7 billion in Q1 2022 to a low of $32.9 million in Q4 2025.
- A 5-year average of $1.3 billion and a median of $1.6 billion in 2022 frame the typical range for Intangibles.
- Annual changes were most pronounced in 2022 — Intangibles increased 3.95% — and 2025, when it tumbled 97.91%.
- Tracing TLRY's Intangibles over 5 years: stood at $1.6 billion in 2022, then fell by 0.89% to $1.6 billion in 2023, then decreased by 1.4% to $1.6 billion in 2024, then plunged by 97.91% to $32.9 million in 2025, then soared by 76.06% to $58.0 million in 2026.
- The last three Intangibles figures came in at $58.0 million (Q2 2026), $37.6 million (Q1 2026), and $32.9 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 3.45 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 918.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 21.28 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 13.68 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 2.23 Bn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 3.20 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 1.12 Bn |
| 10 | Tilray Brands | 513.87 Mn | 279.24 Mn | 90.52 Mn | 58.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 58.00 Mn |
| Feb 28, 2026 | 37.63 Mn |
| Nov 30, 2025 | 32.94 Mn |
| Aug 31, 2025 | 33.84 Mn |
| May 31, 2025 | 1.63 Bn |
| Feb 28, 2025 | 1.57 Bn |
| Nov 30, 2024 | 1.58 Bn |
| Aug 31, 2024 | 1.61 Bn |
| May 31, 2024 | 1.59 Bn |
| Feb 29, 2024 | 1.59 Bn |
| Nov 30, 2023 | 1.60 Bn |
| Aug 31, 2023 | 1.59 Bn |
| May 31, 2023 | 1.58 Bn |
| Feb 28, 2023 | 1.58 Bn |
| Nov 30, 2022 | 1.61 Bn |
| Aug 31, 2022 | 1.59 Bn |
| May 31, 2022 | 1.64 Bn |
| Feb 28, 2022 | 1.66 Bn |
| Nov 30, 2021 | 1.55 Bn |
| Aug 31, 2021 | 1.58 Bn |